Karen Lynch, chief executive officer of CVS Health, described what CVS has been doing to disrupt the traditional landscape of the healthcare industry to The New York Times on Jan. 21.
After three rejected bids, London-based Unilever is throwing in the towel, stating that it will not raise its $68 billion offer to purchase GSK Consumer Healthcare, the joint venture between GlaxoSmithKline and Pfizer, The Wall Street Journal reported …
After three rejected bids, London-based Unilever said it is still interested in purchasing GSK Consumer Healthcare, which is a joint venture between GlaxoSmithKline and Pfizer and makes popular products such as Advil and ChapStick, The New York Times r…